Mirae Asset Global Investments Co. Ltd. Buys New Shares in CME Group Inc. $CME

Key Points

• Mirae Asset Global Investments purchased 90,442 CME Group shares during the third quarter, worth approximately $23.7 million. Institutional investors collectively own 87.75% of the company.
• Analyst sentiment was mixed but generally improved, with JPMorgan and Morgan Stanley raising their ratings or price targets. The stock has an average “Hold” rating and a consensus target price of $314.44.
• CME Group exceeded quarterly expectations, reporting $3.02 in EPS and $1.74 billion in revenue, up 10.6% year over year. Shares opened at $306.24, while the company maintained a quarterly dividend of $1.30 per share.

Mirae Asset Global Investments Co. Ltd. purchased a new stake in shares of CME Group Inc. (NASDAQ:CME - Free Report) during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 90,442 shares of the financial services provider's stock, valued at approximately $23,694,000.

Other institutional investors also recently bought and sold shares of the company. Whipplewood Advisors LLC raised its stake in shares of CME Group by 2,075.0% in the first quarter. Whipplewood Advisors LLC now owns 87 shares of the financial services provider's stock valued at $26,000 after acquiring an additional 83 shares during the period. First Community Trust NA purchased a new position in shares of CME Group during the 3rd quarter worth about $26,000. North Point Portfolio Managers Corp OH purchased a new position in shares of CME Group during the 3rd quarter worth about $26,000. Mowery & Schoenfeld Wealth Management LLC purchased a new position in shares of CME Group during the 2nd quarter worth about $28,000. Finally, Main Street Group LTD bought a new position in CME Group during the 1st quarter valued at about $32,000. 87.75% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

A number of analysts recently weighed in on CME shares. JPMorgan Chase & Co. raised shares of CME Group from an "underweight" rating to an "overweight" rating and set a $367.00 price objective on the stock in a research report on Thursday, October 22nd. Morgan Stanley raised their price objective on shares of CME Group from $337.00 to $359.00 and gave the stock an "overweight" rating in a research note on Thursday, October 22nd. CLSA set a $367.00 target price on CME Group in a research report on Thursday, October 22nd. Barclays upped their target price on CME Group from $281.00 to $321.00 and gave the company an "equal weight" rating in a research note on Thursday, October 22nd. Finally, Bank of America increased their price target on CME Group from $226.00 to $230.00 and gave the stock an "underperform" rating in a report on Thursday, July 23rd. Ten analysts have rated the stock with a Buy rating, six have assigned a Hold rating and two have given a Sell rating to the stock. According to data from MarketBeat, the stock has an average rating of "Hold" and a consensus target price of $314.44.

Insider Buying and Selling at CME Group

In other news, Director Martin Gepsman sold 400 shares of the firm's stock in a transaction that occurred on Thursday, October 22nd. The shares were sold at an average price of $302.50, for a total transaction of $121,000.00. Following the transaction, the director directly owned 25,244 shares of the company's stock, valued at approximately $7,636,310. This trade represents a 1.56% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Elizabeth Cook sold 500 shares of CME Group stock in a transaction that occurred on Monday, September 14th. The shares were sold at an average price of $280.11, for a total transaction of $140,055.00. Following the sale, the director directly owned 17,916 shares of the company's stock, valued at $5,018,450.76. This represents a 2.72% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last quarter, insiders sold 30,979 shares of company stock valued at $8,946,762. 0.30% of the stock is owned by corporate insiders.

CME Group Stock Up 1.0%

Shares of CME opened at $306.24 on Tuesday. The firm has a market capitalization of $110.12 billion, a P/E ratio of 25.12, a P/E/G ratio of 3.59 and a beta of 0.24. CME Group Inc. has a 12-month low of $218.31 and a 12-month high of $329.16. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.13. The firm has a fifty day moving average price of $280.96 and a 200-day moving average price of $280.20.

CME Group (NASDAQ:CME - Get Free Report) last posted its quarterly earnings results on Wednesday, October 21st. The financial services provider reported $3.02 EPS for the quarter, topping the consensus estimate of $2.99 by $0.03. CME Group had a net margin of 63.33% and a return on equity of 16.23%. The company had revenue of $1.74 billion for the quarter, compared to the consensus estimate of $1.71 billion. During the same quarter last year, the firm posted $2.68 EPS. The firm's revenue was up 10.6% compared to the same quarter last year. Equities research analysts expect that CME Group Inc. will post 12.34 earnings per share for the current year.

CME Group Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, September 25th. Shareholders of record on Wednesday, September 9th were paid a $1.30 dividend. This represents a $5.20 dividend on an annualized basis and a yield of 1.7%. The ex-dividend date was Wednesday, September 9th. CME Group's dividend payout ratio is currently 42.66%.

About CME Group

CME Group Inc operates global derivatives marketplaces that provide trading, clearing and settlement services for futures and options contracts. Its products cover major asset classes, including interest rates, equity indexes, foreign currencies, agricultural commodities, energy and metals. The company also provides market data, benchmark information and related services used by financial institutions, corporations, producers, investors and other market participants.

CME Group's exchange portfolio includes CME, the Chicago Board of Trade, the New York Mercantile Exchange and COMEX.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.